Fares would vary according to sector.
This was achieved despite falling tourist arrivals post Babri Masjid demolition in December 1992.
Experts said the risks associated with the Indian Experts say that aviation sector would keep investors away from airline stocks.
Vistara and AirAsia India have been lobbying for the relaxation of this rule.
The combined sales of the branded versions of the products in the US is about $3.5 billion.
The regulator had issued alerts in June and July of 2015.
Carriers' input costs are rising due to weak rupee and rising crude oil price.
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Domestic jet fuel prices are up 7%, but are still 14% lower on a y-o-y basis. While lower fuel prices have brought respite to airlines, their non-fuel costs are rising because of rupee depreciation
Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.
The draft bill allows euthanasia for patients who can take informed decisions; doctors to be protected from liability.
Daiichi alleged that Singh brothers had concealed and misrepresented critical information concerning US Food and Drug Administration and Department of Justice investigations into Ranbaxy
The working groups will comprise representatives of airlines, airport operators and the AAI.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Jet's advertising and that of most other airlines has been limited to new routes or promotional fares.
Etihad is the fourth airline to operate the super jumbo aircraft to India.
Company aims to build five Rs 100 cr-plus brands and launch products from South African arm in domestic market
While the Taj remains popular amongst celebrity guests, many ordinary foreign visitors are skipping it
NHAI to pull plug on Rs 3,000-crore ventures for poor show
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances